InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

PULSE BIOSCIENCES, INC.

PLSE Clue Score37
United States Fiscal year ends December CIK 0001625101 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Kevin Patrick Danahy
18 Feb 2026
Chief Commercial Officer
Sold after exercise
5,000
$23.64
$118.20K
Kevin Patrick Danahy
17 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.63
$472.60K
Kevin Patrick Danahy
13 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.53
$470.60K
Kevin Patrick Danahy
12 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.37
$467.40K
Kevin Patrick Danahy
11 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$25.20
$504.00K
Kevin Patrick Danahy
10 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.52
$470.40K
Kevin Patrick Danahy
9 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$21.45
$429.00K
Show all 13 transactions →

What was left out

Form 4 filings counted 16
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 125,000
History held since 16 Nov 2016